-
Use of antibiotics is associated with increased risk of breast cancer and death from breast cancer in a dose-dependent way.
-
The FDA has approved the first antineoplastic that acts by the inhibiting the formation of new blood vessels in tumors.
-
Migraine and Subclinical Brain Lesions; Memantine Treatment in Alzheimer Disease; PPG in Type 2 DM
-
High-dose atorvastatin protects patients with acute coronary syndrome from death and major cardiovascular events better than usual dose pravastatin.
-
These data provide further support that inflammation in general and periodontal disease more specifically are stroke risk factors.
-
The first of a class of calcimimetics has been approved by the FDA for the treatment of hyperparathyroidism associated with renal failure and in patients with parathyroid cancer.
-
Increased iron stores (eg, ferritin levels) are associated with an increased risk of type 2 diabetes in women.
-
Shared pathophysiologic mechanisms for migraine, neuropathic pain, and epilepsy underscore the notion that antiepileptic drugs (AED) should be standard treatment for the former. Five new AEDs and their use in these nonepileptic painful disorders are summarized.
-
Use of B-Type Natriuretic Peptide in the Evaluation and Management of
Acute Dyspnea; Association Between C-Reactive Protein and Age-Related Macular Degeneration; VZV Reactivation in Astronauts
-
New guidelines for the treatment of bacterial rhinosinusitis were published in the January supplement of Otolaryngology-Head and Neck Surgery by the Sinus and Allergy Health Partnership.
